1965 - Fellow of the American Association for the Advancement of Science (AAAS)
His primary areas of study are Transplantation, Immunology, Xenotransplantation, Antibody and Antigen. Particularly relevant to Heart transplantation is his body of work in Transplantation. His study looks at the relationship between Heart transplantation and fields such as Methylprednisolone, as well as how they intersect with chemical problems.
He interconnects Baboon and Kidney transplantation in the investigation of issues within Immunology. His Xenotransplantation research is multidisciplinary, incorporating elements of Thrombotic microangiopathy, Transgene, Allotransplantation, Organ transplantation and Islet. David K. C. Cooper has included themes like Molecular biology, Cytotoxic T cell, Alpha and Cytotoxicity in his Antibody study.
The scientist’s investigation covers issues in Transplantation, Xenotransplantation, Immunology, Antibody and Internal medicine. David K. C. Cooper specializes in Transplantation, namely Heart transplantation. The Xenotransplantation study combines topics in areas such as Clinical trial, Kidney, Intensive care medicine, Allotransplantation and Organ transplantation.
His biological study spans a wide range of topics, including Peripheral blood mononuclear cell, Thrombotic microangiopathy and Baboon. His Antibody research includes themes of Molecular biology, Cytotoxic T cell, Antigen and Cytotoxicity. His Internal medicine research is multidisciplinary, relying on both Gastroenterology, Endocrinology and Cardiology.
His primary scientific interests are in Xenotransplantation, Transplantation, Immunology, Immune system and Clinical trial. The study incorporates disciplines such as Kidney, Antigen, Intensive care medicine, Allotransplantation and Antibody in addition to Xenotransplantation. His research in Antibody intersects with topics in Peripheral blood mononuclear cell and Flow cytometry.
The concepts of his Transplantation study are interwoven with issues in Bioinformatics and Islet. His Immunology research is multidisciplinary, incorporating perspectives in Transgene, Baboon and Heart transplantation. David K. C. Cooper interconnects Genetically engineered and Disease in the investigation of issues within Clinical trial.
His primary areas of investigation include Xenotransplantation, Transplantation, Immunology, Immune system and Antibody. His work carried out in the field of Xenotransplantation brings together such families of science as Clinical trial, Baboon, Allotransplantation, Kidney and Islet. His Transplantation study is associated with Surgery.
David K. C. Cooper combines subjects such as Peripheral blood mononuclear cell, Thrombotic microangiopathy and Heart transplantation with his study of Immunology. His Immune system research incorporates elements of Andrology, In vitro and Heart valve. His work on IgG binding as part of general Antibody research is often related to N-Glycolylneuraminic acid, thus linking different fields of science.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study.
Julio S. G. Montaner;Peter Reiss;David Cooper;Stefano Vella.
Marked prolongation of porcine renal xenograft survival in baboons through the use of α1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue
Kazuhiko Yamada;Koji Yazawa;Akira Shimizu;Takehiro Iwanaga.
Nature Medicine (2005)
Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: initial experience.
Kenji Kuwaki;Yau Lin Tseng;Frank J.M.F. Dor;Akira Shimizu.
Nature Medicine (2005)
Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation.
Rafael Oriol;Yong Ye;Eugen Koren;David K.C. Cooper.
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents.
Robert W Frenck;Nicola P Klein;Nicholas Kitchin;Alejandra Gurtman.
The New England Journal of Medicine (2021)
Brain death and its influence on donor organ quality and outcome after transplantation.
J. Pratschke;M. J. Wilhelm;M. Kusaka;M. Basker.
Hemodynamic and metabolic responses to hormonal therapy in brain-dead potential organ donors.
D. Novitzky;D. K. C. Cooper;B. Reichart.
Identification of α-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: relevance to discordant xenografting in man
D.K.C. Cooper;A.H. Good;E. Koren;R. Oriol.
Transplant Immunology (1993)
Clinical xenotransplantation: the next medical revolution?
Burcin Ekser;Mohamed Ezzelarab;Hidetaka Hara;Dirk J. Van Der Windt;Dirk J. Van Der Windt;Dirk J. Van Der Windt.
The Lancet (2012)
Spermatogonial Stem Cell Transplantation into Rhesus Testes Regenerates Spermatogenesis Producing Functional Sperm
Brian Peter Hermann;Meena Sukhwani;Felicity Winkler;Julia N. Pascarella.
Cell Stem Cell (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: